Using magnetic resonance imaging (MRI) and nanoparticle technology, researchers from Yale have devised a way to monitor the growth of laboratory-engineered blood vessels after they have been implanted in patients…
Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
2
Dec |
Method Developed To Monitor Engineered Blood Vessels As They Grow In PatientsCategory: Vascular | Leave a Comment |
Using magnetic resonance imaging (MRI) and nanoparticle technology, researchers from Yale have devised a way to monitor the growth of laboratory-engineered blood vessels after they have been implanted in patients…
|
18
Aug |
Incidence Of DVT After Surgery Low When Preventative Steps Taken, But Most Cases Linked To Catheter UseCategory: Vascular | Leave a Comment |
A report published Online First by Archives of Surgery, one of the JAMA/Archives journals suggests, that the incidence of deep vein thrombosis (DVT) after general surgical operations seems to be low when preventive steps are taken, but most cases that do occur are diagnosed in the inpatient setting and most are associated with catheter use…
|
28
Jun |
Off The Shelf Blood Vessels Made With Donor Cells Look FeasibleCategory: Vascular | Leave a Comment |
Blood vessels that are available off the shelf are looking more feasible since the announcement this week that vessels grown in the lab from donor skin cells were successfully implanted into kidney dialysis patients in a small clinical trial…
|
15
Jun |
BDC Laboratories Releases Stent, Stent Graft, And Transcatheter Heart Valve Simulated Use Test SystemsCategory: Vascular | Leave a Comment |
Endovascular stents, stent grafts, and transcatheter heart valve (TAVI) devices provide enhanced methods for clinical treatment of cardiac and vascular disease. Further research and product development is currently ongoing worldwide to address complications associated with these devices…
|
26
May |
Drug-Eluting Stents Using Biodegradable Polymer Significantly Improve Overall Clinical Outcomes And Reduce Stent ThrombosisCategory: Vascular | Leave a Comment |
Drug-eluting stents (DES) using a biodegradable polymer significantly improve overall clinical outcomes and reduce stent thrombosis by 50% compared with DES using a durable polymer over a three-year period. These were the findings from a new independent patient-level meta-analysis involving over 4,000 patients, presented at EuroPCR last week…
|
23
May |
Cordis Receives FDA Approval For EXOSEAL™ Vascular Closure DeviceCategory: Vascular | Leave a Comment |
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the EXOSEAL™ Vascular Closure Device in the US. EXOSEAL™ incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure…
|
17
May |
Medtronic Advances Research On Peripheral Devices, Highlights Upcoming PresentationsCategory: Vascular | Leave a Comment |
A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. (NYSE: MDT) today announced recent milestones in its clinical program for the IN.PACT drug-eluting balloon (DEB) technology. The company also announced upcoming data presentations on its peripheral vascular devices — specifically, the IN…
|
12
May |
New Aspirin Test Now Available Through Diagnostic Laboratory MedicineCategory: Vascular | Leave a Comment |
A simple urine test that measures aspirin effect is now available in the greater Boston and surrounding area. The AspirinWorks® Test is available to eastern Massachusetts and southern New Hampshire area doctors through Diagnostic Laboratory Medicine. Dr…
|
12
May |
New Aspirin Test Now Available Through Diagnostic Laboratory MedicineCategory: Vascular | Leave a Comment |
A simple urine test that measures aspirin effect is now available in the greater Boston and surrounding area. The AspirinWorks® Test is available to eastern Massachusetts and southern New Hampshire area doctors through Diagnostic Laboratory Medicine. Dr…
|
27
Apr |
Mercy Medical Center Installs Toshiba’s Infinix-I Vascular Hybrid System To Help Improve Patient Care And WorkflowCategory: Vascular | Leave a Comment |
Enhancing diagnostic and interventional capabilities to provide the highest level of patient care, The Vascular Center at Mercy Medical Center, Baltimore has installed the InfinixTM VC-i and customized CAT-880B catheterization table from Toshiba America Medical Systems, Inc. for its new state-of-the-art hybrid operating room (OR)…